|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities: | ||||||||||||||||||||
| Bonds available for sale, at fair value, net of allowance for credit losses of $35 in 2026 and $37 in 2025 (amortized cost: 2026 - $72,710; 2025 - $71,772) | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total bonds available for sale, at fair value, net of allowance for credit losses of $35 in 2026 and $37 in 2025 (amortized cost: 2026 - $72,710; 2025 - $71,772) | ||||||||||||||||||||
| Other bond securities, at fair value | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total other bond securities, at fair value | ||||||||||||||||||||
| Mortgage and other loans receivable, net of allowance for credit losses of $617 in 2022 and $629 in 2021 | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total equity securities, at fair value | ||||||||||||||||||||
| Mortgage and other loans receivable, net of allowance for credit losses of $37,714 in 2026 and $37,747 in 2025 | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total mortgage and other loans receivable, net of allowance for credit losses of $37,714 in 2026 and $37,747 in 2025 | ||||||||||||||||||||
| Other invested assets (portion measured at fair value: 2026 - $3,120; 2025 - $5,011) | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Total other invested assets (portion measured at fair value: 2026 - $3,120; 2025 - $5,011) | ||||||||||||||||||||
| Short-term investments, including restricted cash of $58 in 2026 and $55 in 2025 (portion measured at fair value: 2026 - $5,213; 2025 - $5,909) | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total short-term investments, including restricted cash of $58 in 2026 and $55 in 2025 (portion measured at fair value: 2026 - $5,213; 2025 - $5,909) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total accrued investment income | ||||||||||||||||||||
| Premiums and other receivables, net of allowance for credit losses and disputes of $134 in 2026 and $131 in 2025 | ||||||||||||||||||||
| Reinsurance assets, net of allowance for credit losses and disputes | ||||||||||||||||||||
| Fortitude RE | ||||||||||||||||||||
| Excluding Fortitude | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Market risk benefit assets, at fair value | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Total market risk benefit assets, at fair value | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deposit accounting assets, net of allowance for credit losses of $49 in 2026 and $49 in 2025 | ||||||||||||||||||||
| Other assets, including restricted cash of $17 in 2026 and $16 in 2025 (portion measured at fair value: 2026 - $3; 2025 - $135) | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total other assets, including restricted cash of $17 in 2026 and $16 in 2025 (portion measured at fair value: 2026 - $3; 2025 - $135) | ||||||||||||||||||||
| Separate account assets, at fair value | ||||||||||||||||||||
| Total separate account assets, at fair value | ||||||||||||||||||||
| Assets held for sale and assets of discontinued operations | ||||||||||||||||||||
| Assets and Liabilities Held for Sale | ||||||||||||||||||||
| Discontinued Operations | ||||||||||||||||||||
| Total assets held for sale and assets of discontinued operations | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Liability for unpaid losses and loss adjustment expenses, including allowance for credit losses of $14 in 2026 and $14 in 2025 | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Policyholder contract deposits (portion measured at fair value: 2024 - $8,613; 2023 - $7,997) | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Total policyholder contract deposits (portion measured at fair value: 2024 - $8,613; 2023 - $7,997) | ||||||||||||||||||||
| Market risk benefit liabilities, at fair value | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Total market risk benefit liabilities, at fair value | ||||||||||||||||||||
| Other policyholder funds | ||||||||||||||||||||
| Fortitude Re funds withheld payable (portion measured at fair value: 2026 - $(75); 2025 - $(92)) | ||||||||||||||||||||
| Recurring Basis | ||||||||||||||||||||
| Total fortitude Re funds withheld payable (portion measured at fair value: 2026 - $(75); 2025 - $(92)) | ||||||||||||||||||||
| Premiums and other related payables | ||||||||||||||||||||
| Deposit accounting liabilities | ||||||||||||||||||||
| Commissions and premium taxes payable | ||||||||||||||||||||
| Current and deferred income tax liabilities | ||||||||||||||||||||
| Other liabilities (portion measured at fair value: 2026 - $192; 2025 - $162) | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total other liabilities (portion measured at fair value: 2026 - $192; 2025 - $162) | ||||||||||||||||||||
| Short-term and long-term debt | ||||||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | ||||||||||||||||||||
| Consolidated Investments, Including Variable Interest Entities, Primarily Beneficiary | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total short-term and long-term debt | ||||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | ||||||||||||||||||||
| Consolidated Investments, Including Variable Interest Entities, Primarily Beneficiary | ||||||||||||||||||||
| Consolidated Entity, Excluding Consolidated VIE | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total long-term debt | ||||||||||||||||||||
| Liabilities held for sale and liabilities of discontinued operations | ||||||||||||||||||||
| Assets and Liabilities Held for Sale | ||||||||||||||||||||
| Discontinued Operations | ||||||||||||||||||||
| Total liabilities held for sale and liabilities of discontinued operations | ||||||||||||||||||||
| Consolidated VIE | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| AIG shareholders’ equity: | ||||||||||||||||||||
| Series A non-cumulative preferred stock and additional paid in capital, $5.00 par value; 100,000,000 shares authorized; shares issued: 2024 - 0 and 2023 - 20,000; liquidation preference $500 | ||||||||||||||||||||
| Common stock, $2.50 par value; 5,000,000,000 shares authorized; shares issued: 2024 - 1,906,671,492 and 2023 - 1,906,671,492 | ||||||||||||||||||||
| Common stock, $2.50 par value; 5,000,000,000 shares authorized; shares issued: 2026 - 1,906,671,492 and 2025 - 1,906,671,492 | ||||||||||||||||||||
| Treasury stock, at cost; 2026 - 1,381,952,801 shares; 2025 - 1,368,489,324 shares of common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total AIG shareholders’ equity | ||||||||||||||||||||
| Non-redeemable noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
